Vista Pharmaceuticals share news, announcements and annual reports
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Vista Pharmaceuticals Ltd. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹6.45up ₹0.31 (5.05%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹6.14.
29 Oct: open ₹6.26, high ₹6.50, low ₹6.14
52-week range of traded prices to 29 Oct 2026
₹5.32Low, 16 Sep 2026₹10.29High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹40 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 22,495
Vista Pharmaceuticals results
92 filed, newest first. Page 2 of 2.
Feb 2018
Nov 2017
Oct 2017
24 Oct · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....24 Oct · Results
Sep 2017
25 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2017
Jul 2017
May 2017
Apr 2017
1 Apr · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Feb 2017
Nov 2016
Sep 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
Aug 2015
10 Aug · Results
Jun 2015
Feb 2015
Nov 2014
Aug 2014
May 2014
29 May · Results
Mar 2014
Feb 2014
12 Feb · Results
Nov 2013
14 Nov · Results
Aug 2013
16 Aug · Results
14 Aug · Results
May 2013
16 May · Results
Feb 2013
14 Feb · Results
Nov 2012
16 Nov · Results
Aug 2012
17 Aug · Results
May 2012
18 May · Results
Feb 2012
10 Feb · Results
Nov 2011
10 Nov · Results
Aug 2011
18 Aug · Results
May 2011
9 May · Results
Feb 2011
1 Feb · Results
Nov 2010
4 Nov · Results
Financial Results for the Quarter ended September 30, 2010.
Jul 2010
30 Jul · Results
May 2010
Feb 2010